Filing metadata

Accession number
0001628280-23-023348
Form type
Form 3
Filer
Mirati Therapeutics, Inc.
CIK
CIK 1576263
Filed
Jun 23, 2023
Reporting period
Jun 23, 2023
Description
Initial ownership

Explore SEC Filings Hub